White label ELPA - ClinicalTrials.eu

Study Comparing Pirtobrutinib to Bendamustine and Rituximab for Untreated Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Not recruiting

3 1 1 1
Investigated Drugs:
+4
Study on the Effects and Safety of Odronextamab for Adults with Previously Treated B-cell Non-Hodgkin Lymphoma

Not recruiting

2 1 1
Investigated Diseases:
Investigated Drugs:
- Odronextamab
Study Comparing Aflibercept and Placebo for Patients with Macular Telangiectasia Type 1

Not recruiting

3 1 1 1
Investigated Diseases:
- Macular telangiectasia
Investigated Drugs:
- Aflibercept
Study on Aspirin (D,L-Lysine Acetylsalicylate) for Patients with Immune Thrombocytopenia and Cardiovascular Disease

Not recruiting

3 1 1 1
Investigated Diseases:
- Immune thrombocytopenia
Investigated Drugs:
- D,L-Lysine Acetylsalicylate
Study on the Effectiveness of Baricitinib for Patients with Refractory Non-Infectious Uveitis

Not recruiting

3 1 1 1
Investigated Drugs:
Study on Long-Term Safety and Effects of Vosoritide in Children with Achondroplasia

Not recruiting

2 1 1 1
Investigated Diseases:
- Osteochondrodysplasia
Investigated Drugs:
- Vosoritide
Study of MK-2870 for Patients with Advanced or Metastatic Stomach Cancer, Comparing Its Effects to a Drug Combination

Not recruiting

3 1 1 1
Investigated Diseases:
- Adenocarcinoma gastric
- Oesophageal adenocarcinoma
Investigated Drugs:
+1
Study on the Safety and Effects of Navitoclax and Ruxolitinib for Patients with Myelofibrosis and Myeloproliferative Neoplasms

Not recruiting

1 1 1 1
Investigated Diseases:
- Myeloproliferative neoplasm
- Myelofibrosis
Investigated Drugs:
Study on the Effects of Itepekimab for Patients with Non-Cystic Fibrosis Bronchiectasis

Not recruiting

2 1
Investigated Drugs:
- Itepekimab
+3
Study of BT8009 and Pembrolizumab for Patients with Advanced Cancers Expressing Nectin-4

Not recruiting

2 1 1 1
Investigated Drugs:
- ZELENECTIDE PEVEDOTIN
- Pembrolizumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies